Global Oral Proteins And Peptides Market Size, Growth Report 2028

Oral Proteins and Peptides Market By Drug Type (Octreotide, Insulin, Calcitonin, Plecanatide, and Linaclotide), By Application (Hormonal Disorders, Diabetes, Bone Diseases, and Gastric & Digestive Disorders) and By Region: Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 - 2028

Category: Healthcare Report Format : PDF Pages: 166 Report Code: ZMR-3360 Published Date: Apr-2022 Status : Published

Market Size in 2021	Market Forecast in 2028	CAGR (in %)	Base Year
USD 1.24 Billion	USD 8.42 Billion	10.4%	2021

Table Of Content

Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
  - 1.3.1 Market Research Type
  - 1.3.2 Market research methodology
Chapter 2. Executive Summary
- 2.1 Global Oral Proteins and Peptides Market, (2022 - 2028) (USD Billion)
- 2.2 Global Oral Proteins and Peptides Market : snapshot
Chapter 3. Global Oral Proteins and Peptides Market - Industry Analysis
- 3.1 Oral Proteins and Peptides Market: Market Dynamics
- 3.2 Market Drivers
  - 3.2.1 Increase in chronic disease around the world can boost the demand for oral proteins and peptides
- 3.3 Market Restraints
  - 3.3.1. High costs associated with the development and formulation of peptide therapeutics may hinder the market growth
- 3.4 Market Opportunities
  - 3.4.1. Increasing research activities in oral peptide formulations may drive the market during the forecast period
- 3.5 Market Challenges
  - 3.5.1. Difficulties with the metabolism and formulation of therapeutics pose a major challenge to market growth
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
  - 3.7.1 Market attractiveness analysis By Drug Type
  - 3.7.2 Market attractiveness analysis By Application
Chapter 4. Global Oral Proteins and Peptides Market- Competitive Landscape
- 4.1 Company market share analysis
  - 4.1.1 Global Oral Proteins and Peptides Market: company market share, 2021
- 4.2 Strategic development
  - 4.2.1 Acquisitions & mergers
  - 4.2.2 New Product launches
  - 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
  - 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
Chapter 5. Global Oral Proteins and Peptides Market - Drug Type Analysis
- 5.1 Global Oral Proteins and Peptides Market overview: By Drug Type
  - 5.1.1 Global Oral Proteins and Peptides Market share, By Drug Type, 2021 and 2028
- 5.2 Octreotide
  - 5.2.1 Global Oral Proteins and Peptides Market by Octreotide, 2022 - 2028 (USD Billion)
- 5.3 Insulin
  - 5.3.1 Global Oral Proteins and Peptides Market by Insulin, 2022 - 2028 (USD Billion)
- 5.4 Calcitonin
  - 5.4.1 Global Oral Proteins and Peptides Market by Calcitonin, 2022 - 2028 (USD Billion)
- 5.5 Plecanatide
  - 5.5.1 Global Oral Proteins and Peptides Market by Plecanatide, 2022 - 2028 (USD Billion)
- 5.6 Linaclotide
  - 5.6.1 Global Oral Proteins and Peptides Market by Linaclotide, 2022 - 2028 (USD Billion)
Chapter 6. Global Oral Proteins and Peptides Market - Application Analysis
- 6.1 Global Oral Proteins and Peptides Market overview: By Application
  - 6.1.1 Global Oral Proteins and Peptides Market share, By Application, 2021 and 2028
- 6.2 Hormonal Disorders
  - 6.2.1 Global Oral Proteins and Peptides Market by Hormonal Disorders, 2022 - 2028 (USD Billion)
- 6.3 Diabetes
  - 6.3.1 Global Oral Proteins and Peptides Market by Diabetes, 2022 - 2028 (USD Billion)
- 6.4 Bone Diseases
  - 6.4.1 Global Oral Proteins and Peptides Market by Bone Diseases, 2022 - 2028 (USD Billion)
- 6.5 Gastric & Digestive Disorders
  - 6.5.1 Global Oral Proteins and Peptides Market by Gastric & Digestive Disorders, 2022 - 2028 (USD Billion)
Chapter 7. Oral Proteins and Peptides Market - Regional Analysis
- 7.1 Global Oral Proteins and Peptides Market Regional Overview
- 7.2 Global Oral Proteins and Peptides Market Share, by Region, 2021 & 2028 (USD Billion)
- 7.3. North America
  - 7.3.1 North America Oral Proteins and Peptides Market, 2022 - 2028 (USD Billion)
    - 7.3.1.1 North America Oral Proteins and Peptides Market, by Country, 2022 - 2028 (USD Billion)
- 7.4 North America Oral Proteins and Peptides Market, by Drug Type, 2022 - 2028
  - 7.4.1 North America Oral Proteins and Peptides Market, by Drug Type, 2022 - 2028 (USD Billion)
- 7.5 North America Oral Proteins and Peptides Market, by Application, 2022 - 2028
  - 7.5.1 North America Oral Proteins and Peptides Market, by Application, 2022 - 2028 (USD Billion)
- 7.4. Europe
  - 7.4.2 Europe Oral Proteins and Peptides Market, 2022 - 2028 (USD Billion)
    - 7.4.2.1 Europe Oral Proteins and Peptides Market, by Country, 2022 - 2028 (USD Billion)
- 7.4 Europe Oral Proteins and Peptides Market, by Drug Type, 2022 - 2028
  - 7.4.1 Europe Oral Proteins and Peptides Market, by Drug Type, 2022 - 2028 (USD Billion)
- 7.5 Europe Oral Proteins and Peptides Market, by Application, 2022 - 2028
  - 7.5.1 Europe Oral Proteins and Peptides Market, by Application, 2022 - 2028 (USD Billion)
- 7.5. Asia Pacific
  - 7.5.3 Asia Pacific Oral Proteins and Peptides Market, 2022 - 2028 (USD Billion)
    - 7.5.3.1 Asia Pacific Oral Proteins and Peptides Market, by Country, 2022 - 2028 (USD Billion)
- 7.4 Asia Pacific Oral Proteins and Peptides Market, by Drug Type, 2022 - 2028
  - 7.4.1 Asia Pacific Oral Proteins and Peptides Market, by Drug Type, 2022 - 2028 (USD Billion)
- 7.5 Asia Pacific Oral Proteins and Peptides Market, by Application, 2022 - 2028
  - 7.5.1 Asia Pacific Oral Proteins and Peptides Market, by Application, 2022 - 2028 (USD Billion)
- 7.6. Latin America
  - 7.6.4 Latin America Oral Proteins and Peptides Market, 2022 - 2028 (USD Billion)
    - 7.6.4.1 Latin America Oral Proteins and Peptides Market, by Country, 2022 - 2028 (USD Billion)
- 7.4 Latin America Oral Proteins and Peptides Market, by Drug Type, 2022 - 2028
  - 7.4.1 Latin America Oral Proteins and Peptides Market, by Drug Type, 2022 - 2028 (USD Billion)
- 7.5 Latin America Oral Proteins and Peptides Market, by Application, 2022 - 2028
  - 7.5.1 Latin America Oral Proteins and Peptides Market, by Application, 2022 - 2028 (USD Billion)
- 7.7. The Middle-East and Africa
  - 7.7.5 The Middle-East and Africa Oral Proteins and Peptides Market, 2022 - 2028 (USD Billion)
    - 7.7.5.1 The Middle-East and Africa Oral Proteins and Peptides Market, by Country, 2022 - 2028 (USD Billion)
- 7.4 The Middle-East and Africa Oral Proteins and Peptides Market, by Drug Type, 2022 - 2028
  - 7.4.1 The Middle-East and Africa Oral Proteins and Peptides Market, by Drug Type, 2022 - 2028 (USD Billion)
- 7.5 The Middle-East and Africa Oral Proteins and Peptides Market, by Application, 2022 - 2028
  - 7.5.1 The Middle-East and Africa Oral Proteins and Peptides Market, by Application, 2022 - 2028 (USD Billion)
Chapter 8. Company Profiles
- 8.1 Proxima Concepts Limited (Diabetology Ltd.)
  - 8.1.1 Overview
  - 8.1.2 Financials
  - 8.1.3 Product Portfolio
  - 8.1.4 Business Strategy
  - 8.1.5 Recent Developments
- 8.2 Allergan plc
  - 8.2.1 Overview
  - 8.2.2 Financials
  - 8.2.3 Product Portfolio
  - 8.2.4 Business Strategy
  - 8.2.5 Recent Developments
- 8.3 Biocon Limited
  - 8.3.1 Overview
  - 8.3.2 Financials
  - 8.3.3 Product Portfolio
  - 8.3.4 Business Strategy
  - 8.3.5 Recent Developments
- 8.4 Chiasma Inc.
  - 8.4.1 Overview
  - 8.4.2 Financials
  - 8.4.3 Product Portfolio
  - 8.4.4 Business Strategy
  - 8.4.5 Recent Developments
- 8.5 Generex Biotechnology Corp.
  - 8.5.1 Overview
  - 8.5.2 Financials
  - 8.5.3 Product Portfolio
  - 8.5.4 Business Strategy
  - 8.5.5 Recent Developments
- 8.6 Hovione Limited
  - 8.6.1 Overview
  - 8.6.2 Financials
  - 8.6.3 Product Portfolio
  - 8.6.4 Business Strategy
  - 8.6.5 Recent Developments
- 8.7 Synergy Pharmaceuticals Inc.
  - 8.7.1 Overview
  - 8.7.2 Financials
  - 8.7.3 Product Portfolio
  - 8.7.4 Business Strategy
  - 8.7.5 Recent Developments
- 8.8 AstraZeneca plc
  - 8.8.1 Overview
  - 8.8.2 Financials
  - 8.8.3 Product Portfolio
  - 8.8.4 Business Strategy
  - 8.8.5 Recent Developments
- 8.9 Novo Nordisk A/S
  - 8.9.1 Overview
  - 8.9.2 Financials
  - 8.9.3 Product Portfolio
  - 8.9.4 Business Strategy
  - 8.9.5 Recent Developments
- 8.10 Tarsa Therapeutics Inc.
  - 8.10.1 Overview
  - 8.10.2 Financials
  - 8.10.3 Product Portfolio
  - 8.10.4 Business Strategy
  - 8.10.5 Recent Developments
- 8.11 Sanofi S.A.
  - 8.11.1 Overview
  - 8.11.2 Financials
  - 8.11.3 Product Portfolio
  - 8.11.4 Business Strategy
  - 8.11.5 Recent Developments
- 8.12 F. Hoffmann-La Roche AG
  - 8.12.1 Overview
  - 8.12.2 Financials
  - 8.12.3 Product Portfolio
  - 8.12.4 Business Strategy
  - 8.12.5 Recent Developments
- 8.13 Synthetic Biologics Inc.
  - 8.13.1 Overview
  - 8.13.2 Financials
  - 8.13.3 Product Portfolio
  - 8.13.4 Business Strategy
  - 8.13.5 Recent Developments
- 8.14 Novartis International AG.
  - 8.14.1 Overview
  - 8.14.2 Financials
  - 8.14.3 Product Portfolio
  - 8.14.4 Business Strategy
  - 8.14.5 Recent Developments

Table Of Figures

1. Market research Type
2. Market research methodology
3. Global Oral Proteins and Peptides Market, 2022 - 2028 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global Oral Proteins and Peptides Market attractiveness, By Drug Type
6. Global Oral Proteins and Peptides Market attractiveness, By Application
7. Global Oral Proteins and Peptides Market share by Drug Type, 2022 and 2028 (USD Billion)
8. Global Oral Proteins and Peptides Market by Octreotide, 2022 - 2028 (USD Billion)
9. Global Oral Proteins and Peptides Market by Insulin, 2022 - 2028 (USD Billion)
10. Global Oral Proteins and Peptides Market by Calcitonin, 2022 - 2028 (USD Billion)
11. Global Oral Proteins and Peptides Market by Plecanatide, 2022 - 2028 (USD Billion)
12. Global Oral Proteins and Peptides Market by Linaclotide, 2022 - 2028 (USD Billion)
13. Global Oral Proteins and Peptides Market share by Application, 2022 and 2028 (USD Billion)
14. Global Oral Proteins and Peptides Market by Hormonal Disorders, 2022 - 2028 (USD Billion)
15. Global Oral Proteins and Peptides Market by Diabetes, 2022 - 2028 (USD Billion)
16. Global Oral Proteins and Peptides Market by Bone Diseases, 2022 - 2028 (USD Billion)
17. Global Oral Proteins and Peptides Market by Gastric & Digestive Disorders, 2022 - 2028 (USD Billion)
18. Global Oral Proteins and Peptides Market share, by Region, 2022 and 2028
19. North America Oral Proteins and Peptides Market, 2022 - 2028 (USD Billion)
20. Europe Oral Proteins and Peptides Market, 2022 - 2028 (USD Billion)
21. Asia Pacific Oral Proteins and Peptides Market, 2022 - 2028 (USD Billion)
22. Latin America Oral Proteins and Peptides Market, 2022 - 2028 (USD Billion)
23. The Middle-East and Africa Oral Proteins and Peptides Market, 2022 - 2028 (USD Billion)

Table Of Tables

1. Global Oral Proteins and Peptides Market: Snapshot
2. Drivers of the Oral Proteins and Peptides Market: impact analysis
3. North America Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
4. North America Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
5. U.S. Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
6. U.S. Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
7. Canada Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
8. Canada Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
9. Europe Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
10. Europe Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
11. Germany Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
12. Germany Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
13. France Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
14. France Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
15. U.K. Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
16. U.K. Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
17. Italy Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
18. Italy Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
19. Spain Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
20. Spain Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
21. Rest of Europe Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
22. Rest of Europe Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
23. Asia Pacific Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
24. Asia Pacific Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
25. China Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
26. China Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
27. Japan Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
28. Japan Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
29. India Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
30. India Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
31. South Korea Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
32. South Korea Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
33. South-East Asia Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
34. South-East Asia Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
35. Rest of Asia Pacific Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
36. Rest of Asia Pacific Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
37. Latin America Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
38. Latin America Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
39. Brazil Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
40. Brazil Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
41. Mexico Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
42. Mexico Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
43. Rest of Latin America Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
44. Rest of Latin America Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
45. The Middle-East and Africa Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
46. The Middle-East and Africa Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
47. GCC Countries Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
48. GCC Countries Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
49. South Africa Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
50. South Africa Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)
51. Rest of Middle-East Africa Oral Proteins and Peptides Market revenue, By Drug Type, 2022 - 2028 (USD Billion)
52. Rest of Middle-East Africa Oral Proteins and Peptides Market revenue, By Application, 2022 - 2028 (USD Billion)

Methodology

FrequentlyAsked Questions

Which key factors will influence oral proteins and peptides market growth over 2022-2028?

The growing prevalence of chronic disease is the prime factor that is fueling the demand for oral proteins and peptides market. According to recent statistics, approximately 15% of individuals in the United States reported having at minimum two chronic medical illnesses in 2021, compared to only around 11% of older millennials. It is the primary cause of disability and death, as well as the $3.8 trillion in annual healthcare costs in the United States. In addition to this, the increase in the geriatric population which is prone to chronic diseases including diabetes, digestive disorders, and many more are also contributing to the market growth.

What will be the value of the oral proteins and peptides market during 2022-2028?

According to the Zion Market Research report, the global oral proteins and peptides market was worth about 1.24 (USD billion) in 2021 and is predicted to grow to around 8.42 (USD billion) by 2028, with a compound annual growth rate (CAGR) of around 10.4 percent.

Which region will contribute notably towards the oral proteins and peptides market value?

North America is predicted to account for the largest share in the market for oral proteins and peptides during the forecast period. This is majorly due to an increase in the inclination of people for effective treatments and well-developed healthcare infrastructure. Further, the presence of a significant number of major players in the region, as well as growing consumer awareness of the main benefits of oral proteins and peptides, are expected to fuel the market's growth in the near future

Which are the major players leveraging the oral proteins and peptides market growth?

Key players active in the global oral proteins and peptides market are Proxima Concepts Limited (Diabetology Ltd.), Allergan plc, Biocon Limited, Chiasma, Inc., Generex Biotechnology Corp., Hovione Limited, Synergy Pharmaceuticals Inc., AstraZeneca plc, Novo Nordisk A/S, Tarsa Therapeutics Inc., Sanofi S.A., F. Hoffmann-La Roche AG, Synthetic Biologics, Inc., and Novartis International AG.

Choose License Type

Single User License $4199.00 Multi User License $5199.00 Enterprise Access License $7199.00

Request Free Brochure

Ask for Customization

Free Analysis

Inquiry For Buying

List of Contents

Oral Proteins and PeptidesIndustry Prospective:Overview COVID-19 Impact:Growth Drivers Restraints Opportunities Challenges Report Scope Segmentation Recent Developments Regional Landscape Competitive Landscape

RelatedNews

HappyClients

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We have secured system to process your transaction.

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed

Global Oral Proteins And Peptides Market Size, Growth Report 2028

Table Of Content

Table Of Figures

Table Of Tables

Methodology

Which key factors will influence oral proteins and peptides market growth over 2022-2028?

What will be the value of the oral proteins and peptides market during 2022-2028?

Which region will contribute notably towards the oral proteins and peptides market value?

Which are the major players leveraging the oral proteins and peptides market growth?

Choose License Type

List of Contents

How to Order

Disclaimer

FAQs

Return Policy

Sitemap

About Us

Terms and Conditions

Contact Us

Privacy Policy

ZMR in News

Career